Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

HIV-specific CD8+ T cells from elite controllers are primed for survival.

Yan J, Sabbaj S, Bansal A, Amatya N, Shacka JJ, Goepfert PA, Heath SL.

J Virol. 2013 May;87(9):5170-81. doi: 10.1128/JVI.02379-12. Epub 2013 Feb 28.

PMID:
23449791
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.

Van Gulck E, Bracke L, Heyndrickx L, Coppens S, Atkinson D, Merlin C, Pasternak A, Florence E, Vanham G.

PLoS One. 2012;7(5):e37792. doi: 10.1371/journal.pone.0037792. Epub 2012 May 30.

PMID:
22666392
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals.

Trabattoni D, Piconi S, Biasin M, Rizzardini G, Migliorino M, Seminari E, Boasso A, Piacentini L, Villa ML, Maserati R, Clerici M.

AIDS. 2004 Apr 9;18(6):859-69.

PMID:
15060433
[PubMed - indexed for MEDLINE]
4.

Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.

Rinaldo CR Jr, Huang XL, Fan Z, Margolick JB, Borowski L, Hoji A, Kalinyak C, McMahon DK, Riddler SA, Hildebrand WH, Day RB, Mellors JW.

J Virol. 2000 May;74(9):4127-38.

PMID:
10756025
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.

Price DA, Scullard G, Oxenius A, Braganza R, Beddows SA, Kazmi S, Clarke JR, Johnson GE, Weber JN, Phillips RE.

J Virol. 2003 May;77(10):6041-9.

PMID:
12719595
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers.

Ferrando-Martínez S, Casazza JP, Leal M, Machmach K, Muñoz-Fernández MÁ, Viciana P, Koup RA, Ruiz-Mateos E.

J Virol. 2012 Apr;86(7):3667-74. doi: 10.1128/JVI.07034-11. Epub 2012 Jan 25.

PMID:
22278254
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.

Ndhlovu ZM, Proudfoot J, Cesa K, Alvino DM, McMullen A, Vine S, Stampouloglou E, Piechocka-Trocha A, Walker BD, Pereyra F.

J Virol. 2012 Jun;86(12):6959-69. doi: 10.1128/JVI.00531-12. Epub 2012 Apr 18.

PMID:
22514340
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.

Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, McCune JM, Deeks SG.

J Virol. 2008 Jun;82(11):5398-407. doi: 10.1128/JVI.02176-07. Epub 2008 Mar 19.

PMID:
18353945
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1.

Aries SP, Weyrich K, Schaaf B, Hansen F, Dennin RH, Dalhoff K.

Scand J Immunol. 1998 Jul;48(1):86-91.

PMID:
9714415
[PubMed - indexed for MEDLINE]
10.

Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.

Casazza JP, Betts MR, Picker LJ, Koup RA.

J Virol. 2001 Jul;75(14):6508-16.

PMID:
11413318
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.

Oxenius A, Price DA, Dawson SJ, Günthard HF, Fischer M, Perrin L, Ramirez E, Fagard C, Hirschel B, Scullard G, Weber JN, McLean AR, Phillips RE; Swiss HIV cohort study.

AIDS. 2002 Nov 22;16(17):2317-22.

PMID:
12441804
[PubMed - indexed for MEDLINE]
12.

Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load.

Oxenius A, Günthard HF, Hirschel B, Fidler S, Weber JN, Easterbrook PJ, Bell JI, Phillips RE, Price DA.

Eur J Immunol. 2001 Apr;31(4):1115-21.

PMID:
11298336
[PubMed - indexed for MEDLINE]
13.

HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.

Rallón NI, Soriano V, Restrepo C, García-Samaniego J, Labarga P, López M, Peris A, González-Lahoz J, Benito JM.

J Acquir Immune Defic Syndr. 2011 May 1;57(1):1-8.

PMID:
21786458
[PubMed - indexed for MEDLINE]
14.

Elucidating the elite: mechanisms of control in HIV-1 infection.

O'Connell KA, Bailey JR, Blankson JN.

Trends Pharmacol Sci. 2009 Dec;30(12):631-7. doi: 10.1016/j.tips.2009.09.005. Review.

PMID:
19837464
[PubMed - indexed for MEDLINE]
15.

Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.

Killian MS, Johnson C, Teque F, Fujimura S, Levy JA.

J Virol. 2011 Feb;85(4):1696-705. doi: 10.1128/JVI.01120-10. Epub 2010 Dec 8.

PMID:
21147929
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.

Larsson M, Jin X, Ramratnam B, Ogg GS, Engelmayer J, Demoitie MA, McMichael AJ, Cox WI, Steinman RM, Nixon D, Bhardwaj N.

AIDS. 1999 May 7;13(7):767-77.

PMID:
10357375
[PubMed - indexed for MEDLINE]
17.

Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.

Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, Shin LY, Kovacs CM, Rodriguez B, Sieg SF, Teixeira-Johnson L, Gudonis D, Goepfert PA, Lederman MM, Frank I, Makedonas G, Kaul R, Walker BD, Betts MR.

PLoS Pathog. 2010 May 27;6(5):e1000917. doi: 10.1371/journal.ppat.1000917.

PMID:
20523897
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression.

Appay V, Hansasuta P, Sutton J, Schrier RD, Wong JK, Furtado M, Havlir DV, Wolinsky SM, McMichael AJ, Richman DD, Rowland-Jones SL, Spina CA.

AIDS. 2002 Jan 25;16(2):161-70.

PMID:
11807299
[PubMed - indexed for MEDLINE]
19.

Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.

Dillon SM, Friedlander LJ, Rogers LM, Meditz AL, Folkvord JM, Connick E, McCarter MD, Wilson CC.

J Virol. 2011 Jan;85(1):397-409. doi: 10.1128/JVI.01118-10. Epub 2010 Oct 20.

PMID:
20962079
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.

Mendoza D, Royce C, Ruff LE, Ambrozak DR, Quigley MF, Dang T, Venturi V, Price DA, Douek DC, Migueles SA, Connors M.

J Virol. 2012 Apr;86(7):4014-8. doi: 10.1128/JVI.06982-11. Epub 2012 Jan 25.

PMID:
22278241
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk